In vitro determination of specific toxicity in tetanus vaccines

Area of Science:

• Biochemistry
• Neuroscience
• Immunology

Background:

• Tetanus vaccines rely on detoxified tetanus neurotoxin, with current safety testing primarily using in vivo methods due to limitations in in vitro assays.
• Tetanus neurotoxin, a 150 kDa protein from Clostridium tetani, features a 50 kDa light chain with zinc metalloprotease activity.
• This light chain specifically cleaves synaptobrevin, a key protein in neuroexocytosis, at the Q76-F77 peptide bond.

Purpose of the Study:

• To develop a sensitive in vitro assay for quantifying the proteolytic activity of tetanus neurotoxin.
• To establish a reliable method for detecting residual toxin activity in vaccines, overcoming the limitations of current in vivo testing.

Main Methods:

• Utilized a recombinant fragment of synaptobrevin2 (amino acids 1-97) as a substrate to detect tetanus neurotoxin's enzymatic activity.
• Employed a peptide antibody targeting the N-terminal cleavage site of synaptobrevin for sensitive detection of cleavage products.
• Investigated two approaches: immobilizing the substrate on a microtitre plate or performing cleavage in solution followed by plate immobilization and detection.

Main Results:

• Western Blot analysis successfully detected only cleaved substrate, indicating high specificity for the toxin's activity.
• The developed assay demonstrated sensitivity in quantifying proteolytic activity, distinguishing between cleaved and uncleaved synaptobrevin.
• Observed non-specific cleavage of the synaptobrevin substrate when using toxoid or crude toxin, influenced by reaction conditions and protease inhibitors.

Conclusions:

• A sensitive and specific in vitro assay for quantifying tetanus neurotoxin proteolytic activity has been successfully developed.
• This assay holds potential for improving vaccine safety by reliably detecting residual toxin activity, complementing or potentially replacing in vivo methods.
• Further research is needed to optimize conditions and address non-specific cleavage observed with toxoids and crude toxins.